# Lupus low disease activity state attainment in the phase 3 TULIP trials of anifrolumab in active systemic lupus erythematosus

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/lupus-low-disease-activity-state-attainment-in-the-phase-3-tulip-trials-of/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Eric F. Morand,Gabriel Abreu,Richard Furie,Vera Golder,Raj Tummala |
| Citations | 69 |
| DOI | 10.1136/ard-2022-222748 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://ard.bmj.com/content/annrheumdis/82/5/639.full.pdf |
| OpenAlex ID | https://openalex.org/W4317762432 |
| PMID | 36690388 |
| Type | article |
| Year | 2023 |

## Paper authors

- [Vera Golder](https://scholariq.org/researchers/vera-golder/)

## Paper journal

- [Annals of the Rheumatic Diseases](https://scholariq.org/journals/annals-of-the-rheumatic-diseases/)

## Paper primary topic

- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)

## Paper topics

- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [interferon and immune responses](https://scholariq.org/topics/interferon-and-immune-responses/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.